[1] Strand V, Balsa A, Al-Saleh J, et al. Immunogenicity of biologics in chronic inflammatory diseases: a systematic review[J]. BioDrugs, 2017,31:299-316. [2] 李玥熠,赵润生,郑书深.IL-22在银屑病发病机制中的研究进展[J].中国免疫学杂志,2021,37:1149-1154. [3] 郑勇凤,王佳婧,傅超美,等.黄芩的化学成分与药理作用研究进展[J].中成药,2016,38:141-147. [4] 杨欢,杨滢霖,程笑,等.黄芩提取物对脂多糖诱导BV2细胞炎症反应作用及机制探讨[J].中国药学杂志,2018,53:268-272. [5] 滕蕊,郭宁,赵晓丹,等.黄芩提取物局部治疗实验性牙周炎的研究[J].中国美容医学,2020,29:115-119. [6] Kocic H, Damiani G, Stamenkovic B, et al. Dietary compounds as potential modulators of microRNA expression in psoriasis[J]. Ther Adv Chronic Dis, 2019,10:2040622319864805. doi: 10.1177/2040622319864805. [7] Alatas ET, Kara M, Dogan G, et al. Blood microRNA expressions in patients with mild to moderate psoriasis and the relationship between microRNAs and psoriasis activity[J]. An Bras Dermatol, 2020,95:702-707. [8] 邹悦, 蒋燕, 郭顺. 麻黄-桂枝药对对白介素-22诱导的HaCaT细胞分泌CCL20的影响[J]. 辽宁中医杂志, 2018, 45:93-96. [9] 王静,江从军,陈秋.银屑病患者血清IL-17、IL-22、IL-36与IL-36Ra水平的变化及其临床意义[J].中国美容医学,2019,28:77-79. [10] 张鼎伟,王媛,霍佳, 等.miR-142-3p/Sema3A轴调节角质形成细胞增殖凋亡及银屑病皮肤炎症反应[J].中国皮肤性病学杂志,2021,35:127-132. [11] 孙通华,崔艳霞.中医药治疗银屑病的近况[J].中国中医药现代远程教育,2011,9:182-183. [12] 郭宇.中药黄芩的化学成分及药理作用的分析[J].临床医药文献电子杂志,2019,6:137-137. [13] 杨岚. 清热除湿解毒法治疗痤疮湿热证及对皮肤生理指标和主要致病菌影响[D].北京:北京中医药大学,2016:92-93. [14] El-Komy M, Amin I, El-Hawary MS, et al. Upregulation of the miRNA-155, miRNA-210, and miRNA-20b in psoriasis patients and their relation to IL-17[J]. Int J Immunopathol Pharmacol,2020,34.doi:10.1171/2058738420933742. [15] Shen H, Zeng B, Wang C, et al. miR-330 inhibits IL-22-induced keratinocyte proliferation through targeting CTNNB1[J]. Biomed Pharmacother, 2017,91:803-811. [16] Wang R, Wang FF, Cao HW, et al. miR-223 regulates proliferation and apoptosis of IL-22-stimulated HaCat human keratinocyte cell lines via the PTEN/Akt pathway[J]. Life Sci, 2019,230:28-34. |